vs

Side-by-side financial comparison of Estée Lauder Companies (The) (EL) and IQVIA (IQV). Click either name above to swap in a different company.

IQVIA is the larger business by last-quarter revenue ($4.4B vs $4.2B, roughly 1.0× Estée Lauder Companies (The)). IQVIA runs the higher net margin — 11.8% vs 3.8%, a 7.9% gap on every dollar of revenue. On growth, IQVIA posted the faster year-over-year revenue change (10.3% vs 5.6%). Estée Lauder Companies (The) produced more free cash flow last quarter ($1.0B vs $561.0M). Over the past eight quarters, IQVIA's revenue compounded faster (8.1% CAGR vs 3.6%).

Estée Lauder was an American businesswoman. She co-founded her eponymous cosmetics company with her husband, Joseph Lauter. Lauder was the only woman on Time magazine's 1998 list of the 20 most influential business geniuses of the 20th century.

IQVIA Holdings, Inc., headquartered in Durham, North Carolina, is an American company focused on health information technology and clinical research.

EL vs IQV — Head-to-Head

Bigger by revenue
IQV
IQV
1.0× larger
IQV
$4.4B
$4.2B
EL
Growing faster (revenue YoY)
IQV
IQV
+4.6% gap
IQV
10.3%
5.6%
EL
Higher net margin
IQV
IQV
7.9% more per $
IQV
11.8%
3.8%
EL
More free cash flow
EL
EL
$456.0M more FCF
EL
$1.0B
$561.0M
IQV
Faster 2-yr revenue CAGR
IQV
IQV
Annualised
IQV
8.1%
3.6%
EL

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
EL
EL
IQV
IQV
Revenue
$4.2B
$4.4B
Net Profit
$162.0M
$514.0M
Gross Margin
76.5%
Operating Margin
9.5%
14.4%
Net Margin
3.8%
11.8%
Revenue YoY
5.6%
10.3%
Net Profit YoY
127.5%
17.6%
EPS (diluted)
$0.44
$2.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EL
EL
IQV
IQV
Q4 25
$4.2B
$4.4B
Q3 25
$3.5B
$4.1B
Q2 25
$3.4B
$4.0B
Q1 25
$3.5B
$3.8B
Q4 24
$4.0B
$4.0B
Q3 24
$3.4B
$3.9B
Q2 24
$3.9B
$3.8B
Q1 24
$3.9B
$3.7B
Net Profit
EL
EL
IQV
IQV
Q4 25
$162.0M
$514.0M
Q3 25
$47.0M
$331.0M
Q2 25
$-546.0M
$266.0M
Q1 25
$159.0M
$249.0M
Q4 24
$-590.0M
$437.0M
Q3 24
$-156.0M
$285.0M
Q2 24
$-286.0M
$363.0M
Q1 24
$335.0M
$288.0M
Gross Margin
EL
EL
IQV
IQV
Q4 25
76.5%
Q3 25
73.4%
Q2 25
72.0%
Q1 25
75.0%
Q4 24
76.1%
Q3 24
72.4%
23.5%
Q2 24
71.8%
22.6%
Q1 24
71.9%
22.1%
Operating Margin
EL
EL
IQV
IQV
Q4 25
9.5%
14.4%
Q3 25
4.9%
13.5%
Q2 25
-11.4%
12.6%
Q1 25
8.6%
13.0%
Q4 24
-14.5%
15.8%
Q3 24
-3.6%
14.1%
Q2 24
-6.0%
13.6%
Q1 24
13.5%
13.5%
Net Margin
EL
EL
IQV
IQV
Q4 25
3.8%
11.8%
Q3 25
1.4%
8.1%
Q2 25
-16.0%
6.6%
Q1 25
4.5%
6.5%
Q4 24
-14.7%
11.0%
Q3 24
-4.6%
7.3%
Q2 24
-7.4%
9.5%
Q1 24
8.5%
7.7%
EPS (diluted)
EL
EL
IQV
IQV
Q4 25
$0.44
$2.97
Q3 25
$0.13
$1.93
Q2 25
$-1.52
$1.54
Q1 25
$0.44
$1.40
Q4 24
$-1.64
$2.41
Q3 24
$-0.43
$1.55
Q2 24
$-0.79
$1.97
Q1 24
$0.91
$1.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EL
EL
IQV
IQV
Cash + ST InvestmentsLiquidity on hand
$2.1B
Total DebtLower is stronger
$7.3B
Stockholders' EquityBook value
$4.0B
$6.5B
Total Assets
$19.6B
$29.9B
Debt / EquityLower = less leverage
1.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EL
EL
IQV
IQV
Q4 25
$2.1B
Q3 25
$2.0B
Q2 25
$2.2B
Q1 25
$1.9B
Q4 24
$1.8B
Q3 24
$1.7B
Q2 24
$1.7B
Q1 24
$1.6B
Total Debt
EL
EL
IQV
IQV
Q4 25
$7.3B
Q3 25
$7.3B
Q2 25
$7.3B
Q1 25
$7.3B
Q4 24
$7.3B
Q3 24
$7.3B
Q2 24
$7.3B
Q1 24
$7.3B
Stockholders' Equity
EL
EL
IQV
IQV
Q4 25
$4.0B
$6.5B
Q3 25
$3.9B
$6.2B
Q2 25
$3.9B
$5.8B
Q1 25
$4.3B
$6.0B
Q4 24
$4.2B
$6.1B
Q3 24
$5.1B
$7.0B
Q2 24
$5.3B
$6.7B
Q1 24
$5.7B
$6.3B
Total Assets
EL
EL
IQV
IQV
Q4 25
$19.6B
$29.9B
Q3 25
$19.3B
$28.7B
Q2 25
$19.9B
$28.6B
Q1 25
$19.9B
$27.3B
Q4 24
$19.8B
$26.9B
Q3 24
$21.3B
$27.2B
Q2 24
$21.7B
$26.4B
Q1 24
$22.7B
$26.6B
Debt / Equity
EL
EL
IQV
IQV
Q4 25
1.82×
Q3 25
1.88×
Q2 25
1.89×
Q1 25
1.68×
Q4 24
1.75×
Q3 24
1.44×
Q2 24
1.37×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EL
EL
IQV
IQV
Operating Cash FlowLast quarter
$1.1B
$735.0M
Free Cash FlowOCF − Capex
$1.0B
$561.0M
FCF MarginFCF / Revenue
24.0%
12.9%
Capex IntensityCapex / Revenue
2.6%
4.0%
Cash ConversionOCF / Net Profit
6.94×
1.43×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$2.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EL
EL
IQV
IQV
Q4 25
$1.1B
$735.0M
Q3 25
$-340.0M
$908.0M
Q2 25
$601.0M
$443.0M
Q1 25
$284.0M
$568.0M
Q4 24
$1.1B
$885.0M
Q3 24
$-670.0M
$721.0M
Q2 24
$889.0M
$588.0M
Q1 24
$534.0M
$522.0M
Free Cash Flow
EL
EL
IQV
IQV
Q4 25
$1.0B
$561.0M
Q3 25
$-436.0M
$772.0M
Q2 25
$394.0M
$292.0M
Q1 25
$162.0M
$426.0M
Q4 24
$925.0M
$721.0M
Q3 24
$-811.0M
$571.0M
Q2 24
$672.0M
$445.0M
Q1 24
$359.0M
$377.0M
FCF Margin
EL
EL
IQV
IQV
Q4 25
24.0%
12.9%
Q3 25
-12.5%
18.8%
Q2 25
11.6%
7.3%
Q1 25
4.6%
11.1%
Q4 24
23.1%
18.2%
Q3 24
-24.1%
14.7%
Q2 24
17.4%
11.7%
Q1 24
9.1%
10.1%
Capex Intensity
EL
EL
IQV
IQV
Q4 25
2.6%
4.0%
Q3 25
2.8%
3.3%
Q2 25
6.1%
3.8%
Q1 25
3.4%
3.7%
Q4 24
3.3%
4.1%
Q3 24
4.2%
3.9%
Q2 24
5.6%
3.7%
Q1 24
4.4%
3.9%
Cash Conversion
EL
EL
IQV
IQV
Q4 25
6.94×
1.43×
Q3 25
-7.23×
2.74×
Q2 25
1.67×
Q1 25
1.79×
2.28×
Q4 24
2.03×
Q3 24
2.53×
Q2 24
1.62×
Q1 24
1.59×
1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EL
EL

Skin Care$2.1B49%
Makeup$1.2B28%
Fragrance$812.0M19%
Hair Care$168.0M4%
Other$31.0M1%

IQV
IQV

Segment breakdown not available.

Related Comparisons